Iterum Therapeutics Earning Date (ITRM)

USA |NASDAQ |USD

ITRM Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 13, 2022 (est) Jun 30, 2022 - - $-0.04
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 13, 2022 (est) Jun 30, 2022 - - $0.00

Iterum Therapeutics's next estimated earnings date (based on same quarter last year's date) is Aug 13, 2022 for the fiscal quarter ending Jun 30, 2022.

ITRM Earnings Date & History Chart

ITRM Earnings & Revenue Forecast

ITRM Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 1 $-0.07 $-0.07 $-0.07
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $-0.26 $-0.26 $-0.26
Dec 2023 1 $-0.30 $-0.30 $-0.30

ITRM Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 0 / 0 $-0.07 $-0.07 $-0.07
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-0.26 $-0.26 $-0.26
Dec 2023 0 / 0 $-0.29 $-0.29 $-0.29

ITRM Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 1 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $0.00 $0.00 $0.00
Dec 2023 1 $0.00 $0.00 $0.00

ITRM Earnings Date & Revenue History

ITRM Earnings History

|
Show More
Show More

ITRM Revenue History

|
Show More
Show More

Iterum Therapeutics Next Earnings Date & Report

ITRM May 2022 (FQ) Earnings Date & Report Preview

ITRM's next estimated earnings date (based on same quarter last year's report date) is Aug 13, 2022 for the fiscal quarter ending Jun 30, 2022.

Iterum Therapeutics Previous Earnings Dates & Reports

ITRM Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Iterum Therapeutics's previous earnings date was May 12, 2022 for its fiscal quarter ended Mar 31, 2022.

ITRM Previous Earnings Date & Report Recap: Dec 2021 (FY)

Iterum Therapeutics's previous annual earnings date was Mar 28, 2022 for its fiscal year ended Dec 31, 2021.

ITRM's earnings per share (EPS) was $-0.14, beating the consensus analysts forecast of $-0.57 by -75.44% , and higher than the previous year's EPS (Dec 2020) by -92.67%.

Revenues were $0.00.

The company reported a net income of $-91.56M.

Iterum Therapeutics reported a free cash flow of $-15.90M for its fiscal year, compared to $-54.54M a year ago.

The company ended the fiscal year with $10.18M in total debt, a decrease of -75.95% compared to the previous year.